Decibel Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Decibel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
  • Decibel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $1.37M, a 62.3% increase year-over-year.
  • Decibel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $3.86M, a 24.8% increase year-over-year.
  • Decibel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.2M, a 13.6% increase from 2021.
  • Decibel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.82M, a 0.11% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.2M +$383K +13.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $2.82M +$3K +0.11% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $2.81M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.